Company intelligence / Profile preview

Global Diabetes Consulting

Fountain Hills, Arizona, United States

Ownership: Private
Development stage: Other

Overview

Global Diabetes Consulting is a small private healthcare consulting firm focused on diabetes and related metabolic disease strategy rather than proprietary drug development. Public references indicate it was founded in 2006 and is led by Larry K. Ellingson, a longtime diabetes industry executive and former American Diabetes Association board chair. The firm appears to provide advisory and consulting services to companies and institutions in the diabetes sector, drawing on expertise in pharmaceutical development, medical devices, regulatory matters, strategic marketing, and stakeholder engagement. There is no evidence that the company operates a therapeutic pipeline or markets its own approved medicines or devices.

Therapeutic areas: Endocrinology
Industry: Consulting

Beyond the preview

Go deeper on Global Diabetes Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Global Diabetes Consulting.

Explore the full profile